Nicholas Stong

4.8k total citations
28 papers, 471 citations indexed

About

Nicholas Stong is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Nicholas Stong has authored 28 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Oncology. Recurrent topics in Nicholas Stong's work include Multiple Myeloma Research and Treatments (9 papers), Genomics and Rare Diseases (4 papers) and Protein Degradation and Inhibitors (4 papers). Nicholas Stong is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Genomics and Rare Diseases (4 papers) and Protein Degradation and Inhibitors (4 papers). Nicholas Stong collaborates with scholars based in United States, France and Netherlands. Nicholas Stong's co-authors include Zhong Deng, Paul M. Lieberman, Harold Riethman, Zhuo Wang, Ramana V. Davuluri, Robert N. Plasschaert, David B. Goldstein, Marisa S. Bartolomei, Vandana Shashi and Marie McDonald and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Nicholas Stong

27 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Stong United States 11 330 157 95 60 53 28 471
Amanda Guffei Canada 10 253 0.8× 136 0.9× 52 0.5× 28 0.5× 114 2.2× 10 365
Jay F. Sarthy United States 10 433 1.3× 86 0.5× 36 0.4× 33 0.6× 44 0.8× 24 531
Alysia R. Bryll United States 6 378 1.1× 186 1.2× 22 0.2× 9 0.1× 105 2.0× 6 527
Wenbing Xie China 13 636 1.9× 65 0.4× 70 0.7× 17 0.3× 94 1.8× 19 739
Hsiao P. J. Voon Australia 13 507 1.5× 105 0.7× 115 1.2× 70 1.2× 35 0.7× 16 638
Judit Pampalona Spain 11 282 0.9× 132 0.8× 38 0.4× 7 0.1× 45 0.8× 14 401
Jeffrey Finklestein United States 6 233 0.7× 49 0.3× 40 0.4× 17 0.3× 36 0.7× 9 376
Naomi Tsuchida Japan 11 143 0.4× 24 0.2× 90 0.9× 33 0.6× 29 0.5× 49 391
Maheshi Udugama Australia 13 818 2.5× 63 0.4× 67 0.7× 16 0.3× 26 0.5× 14 875
Si‐Qi Chen China 8 437 1.3× 104 0.7× 36 0.4× 8 0.1× 308 5.8× 13 603

Countries citing papers authored by Nicholas Stong

Since Specialization
Citations

This map shows the geographic impact of Nicholas Stong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Stong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Stong more than expected).

Fields of papers citing papers by Nicholas Stong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Stong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Stong. The network helps show where Nicholas Stong may publish in the future.

Co-authorship network of co-authors of Nicholas Stong

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Stong. A scholar is included among the top collaborators of Nicholas Stong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Stong. Nicholas Stong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chow, Tracy T., Nicholas Stong, Chad C. Bjorklund, et al.. (2024). Biomarker Analyses of the CC-92480-MM-001 Trial to Guide Combinatorial Strategies for Mezigdomide. Blood. 144(Supplement 1). 3261–3261. 1 indexed citations
3.
Amatangelo, Michael, Erin Flynt, Nicholas Stong, et al.. (2024). Pharmacodynamic changes in tumor and immune cells drive iberdomide’s clinical mechanisms of activity in relapsed and refractory multiple myeloma. Cell Reports Medicine. 5(6). 101571–101571. 6 indexed citations
4.
Sullivan, Jennifer A., Rebecca C. Spillmann, Kelly Schoch, et al.. (2023). The best of both worlds: Blending cutting‐edge research with clinical processes for a productive exome clinic. Clinical Genetics. 105(1). 62–71.
5.
Hayeck, Tristan J., Nicholas Stong, Evan H. Baugh, et al.. (2022). Ancestry adjustment improves genome-wide estimates of regional intolerance. Genetics. 221(2). 2 indexed citations
6.
Ansari‐Pour, Naser, Mehmet Samur, Erin Flynt, et al.. (2022). Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma. Blood. 141(6). 620–633. 22 indexed citations
7.
Stong, Nicholas, Fadi Towfic, Mehmet Samur, et al.. (2022). The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM. Blood. 141(13). 1574–1583. 21 indexed citations
8.
Towfic, Fadi, Erin Flynt, Nicholas Stong, et al.. (2021). Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways. BMC Medical Genomics. 14(1). 295–295. 8 indexed citations
9.
McDonald, Marie, Allyn McConkie‐Rosell, Nicholas Stong, et al.. (2020). Epileptic encephalopathy with features of rapid‐onset dystonia Parkinsonism and alternating hemiplegia of childhood: a novel combination phenotype associated with ATP1A3 mutation. Epileptic Disorders. 22(1). 103–109. 6 indexed citations
10.
Schoch, Kelly, Queenie K.‐G. Tan, Nicholas Stong, et al.. (2020). Alternative transcripts in variant interpretation: the potential for missed diagnoses and misdiagnoses. Genetics in Medicine. 22(7). 1269–1275. 23 indexed citations
11.
Jian, Chu, Winston Lee, Nicholas Stong, et al.. (2019). Late-onset pattern macular dystrophy mimicking ABCA4 and PRPH2 disease is caused by a homozygous frameshift mutation in ROM1. Molecular Case Studies. 5(3). a003624–a003624. 7 indexed citations
12.
Wolock, Charles J., Nicholas Stong, Chu Jian, et al.. (2019). A case–control collapsing analysis identifies retinal dystrophy genes associated with ophthalmic disease in patients with no pathogenic ABCA4 variants. Genetics in Medicine. 21(10). 2336–2344. 26 indexed citations
13.
Hayeck, Tristan J., Nicholas Stong, Charles J. Wolock, et al.. (2019). Improved Pathogenic Variant Localization via a Hierarchical Model of Sub-regional Intolerance. The American Journal of Human Genetics. 104(2). 299–309. 21 indexed citations
14.
Lee, Winston, Jana Zernant, Nicholas Stong, et al.. (2019). Modification of the PROM1 disease phenotype by a mutation in ABCA4. Ophthalmic Genetics. 40(4). 369–375. 17 indexed citations
15.
Wattacheril, Julia, Patrick R. Shea, Saeed Mohammad, et al.. (2018). Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease. Molecular Case Studies. 4(5). a003087–a003087. 3 indexed citations
16.
Cope, Heidi, Rebecca C. Spillmann, Nicholas Stong, et al.. (2018). Further evidence for the involvement of EFL1 in a Shwachman–Diamond-like syndrome and expansion of the phenotypic features. Molecular Case Studies. 4(5). a003046–a003046. 22 indexed citations
17.
Rotemberg, Veronica, Maria C. Garzón, Christine T. Lauren, et al.. (2017). A Novel Mutation in Junctional Plakoglobin Causing Lethal Congenital Epidermolysis Bullosa. The Journal of Pediatrics. 191. 266–269.e1. 6 indexed citations
18.
Stong, Nicholas, Olga Vladimirova, Andreas Wiedmer, et al.. (2015). Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. The EMBO Journal. 35(2). 193–207. 48 indexed citations
19.
Stong, Nicholas, Zhong Deng, Ravi Gupta, et al.. (2014). Subtelomeric CTCF and cohesin binding site organization using improved subtelomere assemblies and a novel annotation pipeline. Genome Research. 24(6). 1039–1050. 51 indexed citations
20.
Deng, Zhong, Zhuo Wang, Nicholas Stong, et al.. (2012). A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. The EMBO Journal. 31(21). 4165–4178. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Guffei Breakdown of academic impact, for papers by Jay F. Sarthy Breakdown of academic impact, for papers by Alysia R. Bryll Breakdown of academic impact, for papers by Wenbing Xie Breakdown of academic impact, for papers by Hsiao P. J. Voon Breakdown of academic impact, for papers by Judit Pampalona Breakdown of academic impact, for papers by Jeffrey Finklestein Breakdown of academic impact, for papers by Naomi Tsuchida Breakdown of academic impact, for papers by Maheshi Udugama Breakdown of academic impact, for papers by Si‐Qi Chen
Rankless by CCL
2026